Anavex has a unique approach to analyzing responses to drugs in humans. Their trials reflect anticipation of functional change in mechanisms far upstream from the degenerative symptoms normally used for end point criteria. Since no diagnostic tools exist to monitor these upstream processes, Anavex has to uses complex analysis of data from downstream measurements.
Tying together the genetic, cellular processes that create health or pathology is ground breaking research and sits apart from the norm of just trying to incur a reduction in a symptom from a disease.
Sometime after these efforts have produced life changing results in millions of people, Anavex will be given credit for this undertaking, by the Medical Establishment, Wall Street and Main Stream Media. For now they sit in the purgatory of misunderstanding, disbelief, skepticism and ridicule by anyone with access to the Internet.
How long will it take to get data lock and results from the Rett Excellence trial?
As long as it takes. And everyone should be as excited as Dr. Missling while they sit here in judgement of a Company bringing the miracle of salvation from CNS degeneration.
Market Data 
Markets 
AI
